MaxCyte (MXCT) Stock Chart & Stock Price History GBX 315 -5.00 (-1.56%) As of 02/21/2025 11:39 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesInsider Trades MaxCyte Stock Price Performance 5 Day Performance-4.31%1 Month Performance-21.77%3 Month Performance+14.55%6 Month Performance0.00%Year-To-Date Performance-1.93%1 Year Performance-12.13% Receive MXCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MaxCyte and its competitors with MarketBeat's FREE daily newsletter. Email Address MXCT Stock Chart for Saturday, February, 22, 2025 MXCT Chart by TradingView MaxCyte Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025GBX 316.52GBX 315-0.48%GBX 315GBX 3105,050 shs£415.81 million02/20/2025GBX 317.48GBX 316.52-0.30%GBX 316.52GBX 3107,172 shs£417.82 million02/19/2025GBX 324GBX 317.48-2.01%GBX 325GBX 31222,737 shs£419.09 million02/18/2025GBX 329.20GBX 324-1.58%GBX 331.84GBX 32436,202 shs£427.69 million02/17/2025GBX 328GBX 329.20+0.37%GBX 329.20GBX 32423,308 shs£434.56 million02/14/2025GBX 330GBX 328-0.61%GBX 330GBX 32052,205 shs£432.97 million02/13/2025GBX 330GBX 330GBX 332GBX 32419,056 shs£435.61 million02/12/2025GBX 340GBX 330-2.94%GBX 350GBX 32515,103 shs£346.80 million02/11/2025GBX 358GBX 340-5.03%GBX 360GBX 34014,471 shs£357.31 million02/10/2025GBX 353GBX 358+1.42%GBX 358GBX 35025,884 shs£376.22 million Get the Latest News and Ratings for MXCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MaxCyte and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025GBX 350GBX 353+0.86%GBX 360GBX 35344,235 shs£370.97 million02/06/2025GBX 352GBX 350-0.57%GBX 366GBX 35016,965 shs£367.82 million02/05/2025GBX 340GBX 352+3.53%GBX 353GBX 3431,839 shs£369.92 million02/04/2025GBX 351GBX 340-3.13%GBX 358GBX 34010,734 shs£357.31 million02/03/2025GBX 378GBX 351-7.14%GBX 365GBX 350.5022,035 shs£368.87 million01/31/2025GBX 377GBX 378+0.27%GBX 380GBX 36444,907 shs£397.24 million01/30/2025GBX 375GBX 377+0.53%GBX 384GBX 370102,665 shs£396.19 million01/29/2025GBX 365GBX 375+2.74%GBX 375.80GBX 36465,030 shs£394.09 million01/28/2025GBX 364GBX 365+0.27%GBX 370GBX 36056,359 shs£383.58 million01/27/2025GBX 383.92GBX 364-5.19%GBX 381.96GBX 36449,894 shs£382.53 million01/24/2025GBX 402GBX 383.92-4.50%GBX 403.60GBX 38049,945 shs£403.46 million01/23/2025GBX 402.66GBX 402-0.16%GBX 406.90GBX 40258,333 shs£422.46 million01/22/2025GBX 404GBX 402.66-0.33%GBX 407GBX 40228,330 shs£423.16 million01/21/2025GBX 390.66GBX 404+3.41%GBX 407.84GBX 39441,861 shs£424.56 million Related Companies Herald Stock Chart Ocean Wilsons Stock Chart PayPoint Stock Chart Resolute Mining Stock Chart Chesnara Stock Chart TruFin Stock Chart Staffline Group Stock Chart Creightons Stock Chart Arcontech Group Stock Chart Neo Energy Metals Stock Chart Receive MXCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MaxCyte and its competitors with MarketBeat's FREE daily newsletter. This page (LON:MXCT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MaxCyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MaxCyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.